442 related articles for article (PubMed ID: 11982604)
1. Inflammatory responses in Ebola virus-infected patients.
Baize S; Leroy EM; Georges AJ; Georges-Courbot MC; Capron M; Bedjabaga I; Lansoud-Soukate J; Mavoungou E
Clin Exp Immunol; 2002 Apr; 128(1):163-8. PubMed ID: 11982604
[TBL] [Abstract][Full Text] [Related]
2. Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype).
Hutchinson KL; Villinger F; Miranda ME; Ksiazek TG; Peters CJ; Rollin PE
J Med Virol; 2001 Nov; 65(3):561-6. PubMed ID: 11596094
[TBL] [Abstract][Full Text] [Related]
3. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.
Wauquier N; Becquart P; Padilla C; Baize S; Leroy EM
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957152
[TBL] [Abstract][Full Text] [Related]
4. Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooué-Ivindo region, Northeastern Gabon, 1997.
Heffernan RT; Pambo B; Hatchett RJ; Leman PA; Swanepoel R; Ryder RW
J Infect Dis; 2005 Mar; 191(6):964-8. PubMed ID: 15717273
[TBL] [Abstract][Full Text] [Related]
5. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues.
Georges AJ; Leroy EM; Renaut AA; Benissan CT; Nabias RJ; Ngoc MT; Obiang PI; Lepage JP; Bertherat EJ; Bénoni DD; Wickings EJ; Amblard JP; Lansoud-Soukate JM; Milleliri JM; Baize S; Georges-Courbot MC
J Infect Dis; 1999 Feb; 179 Suppl 1():S65-75. PubMed ID: 9988167
[TBL] [Abstract][Full Text] [Related]
6. Human asymptomatic Ebola infection and strong inflammatory response.
Leroy EM; Baize S; Volchkov VE; Fisher-Hoch SP; Georges-Courbot MC; Lansoud-Soukate J; Capron M; Debré P; McCormick JB; Georges AJ
Lancet; 2000 Jun; 355(9222):2210-5. PubMed ID: 10881895
[TBL] [Abstract][Full Text] [Related]
7. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.
Baize S; Leroy EM; Georges-Courbot MC; Capron M; Lansoud-Soukate J; Debré P; Fisher-Hoch SP; McCormick JB; Georges AJ
Nat Med; 1999 Apr; 5(4):423-6. PubMed ID: 10202932
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995.
Busico KM; Marshall KL; Ksiazek TG; Roels TH; Fleerackers Y; Feldmann H; Khan AS; Peters CJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S102-7. PubMed ID: 9988172
[TBL] [Abstract][Full Text] [Related]
9. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.
Gupta M; MacNeil A; Reed ZD; Rollin PE; Spiropoulou CF
Virology; 2012 Feb; 423(2):119-24. PubMed ID: 22197674
[TBL] [Abstract][Full Text] [Related]
10. Cytokine and chemokine expression in humans infected with Sudan Ebola virus.
Hutchinson KL; Rollin PE
J Infect Dis; 2007 Nov; 196 Suppl 2():S357-63. PubMed ID: 17940971
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.
Mupapa K; Massamba M; Kibadi K; Kuvula K; Bwaka A; Kipasa M; Colebunders R; Muyembe-Tamfum JJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S18-23. PubMed ID: 9988160
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.
Thom R; Tipton T; Strecker T; Hall Y; Akoi Bore J; Maes P; Raymond Koundouno F; Fehling SK; Krähling V; Steeds K; Varghese A; Bailey G; Matheson M; Kouyate S; Coné M; Moussa Keita B; Kouyate S; Richard Ablam A; Laenen L; Vergote V; Guiver M; Timothy J; Atkinson B; Ottowell L; Richards KS; Bosworth A; Longet S; Mellors J; Pannetier D; Duraffour S; Muñoz-Fontela C; Sow O; Koivogui L; Newman E; Becker S; Sprecher A; Raoul H; Hiscox J; Henao-Restrepo AM; Sakoba K; Magassouba N; Günther S; Kader Konde M; Carroll MW
Lancet Infect Dis; 2021 Apr; 21(4):507-516. PubMed ID: 33065039
[TBL] [Abstract][Full Text] [Related]
13. Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
Rao M; Bray M; Alving CR; Jahrling P; Matyas GR
J Virol; 2002 Sep; 76(18):9176-85. PubMed ID: 12186901
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014⁻2016 Outbreak in West Africa.
Colavita F; Biava M; Castilletti C; Lanini S; Miccio R; Portella G; Vairo F; Ippolito G; Capobianchi MR; Di Caro A; Lalle E
Viruses; 2019 Apr; 11(4):. PubMed ID: 31018522
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G in Ebola outbreak survivors, Gabon.
Wauquier N; Becquart P; Gasquet C; Leroy EM
Emerg Infect Dis; 2009 Jul; 15(7):1136-7. PubMed ID: 19624943
[No Abstract] [Full Text] [Related]
17. ELISA for the detection of antibodies to Ebola viruses.
Ksiazek TG; West CP; Rollin PE; Jahrling PB; Peters CJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S192-8. PubMed ID: 9988184
[TBL] [Abstract][Full Text] [Related]
18. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
[TBL] [Abstract][Full Text] [Related]
19. Loss of Interleukin 1 Receptor Antagonist Enhances Susceptibility to Ebola Virus Infection.
Hill-Batorski L; Halfmann P; Marzi A; Lopes TJ; Neumann G; Feldmann H; Kawaoka Y
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S329-35. PubMed ID: 26209680
[TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence method for detection of Ebola virus immunoglobulin g, using HeLa cells which express recombinant nucleoprotein.
Saijo M; Niikura M; Morikawa S; Kurane I
J Clin Microbiol; 2001 Feb; 39(2):776-8. PubMed ID: 11158150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
